Explore our newsroom for Symani press releases, news stories, and journalist resources.
Stay up to date with the latest Symani news
Subscribe for timely email updates from MMI
"*" indicates required fields
‘Under the Microscope’ highlights the promise of robotic-assisted microsurgery for breast cancer reconstruction
MMI Expands Global Footprint with Entry into Asia Pacific Market
MMI’s Symani® Robotic Surgical System Surpasses 500 Clinical Procedures
MMI Named One of Fast Company’s 2023 “World’s Most Innovative Companies”
Massimiliano Simi, VP R&D & Co-Founder of MMI: “We aim to revolutionize microsurgery”
Breakthrough Robotic System Promises to Revolutionize Microsurgery
Supermicrosurgery Could Lengthen the Reach of Robotics
Big Hopes for Microsurgical Robots
The Future is Now: Jamie Milas of Medical Microinstruments (MMI) on How Their Technological Innovation Will Shake Up the Tech Scene
Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments
Miniaturized Surgical Robotic Instruments Expand the Possibilities of Surgical Interventions
5022 Gate Parkway,
Building 500,
Jacksonville, FL 32256
The Symani Surgical System is authorized for use in the U.S. by the FDA and is a CE marked medical device. Clinical indications vary by geography. Refer to global indications for more information. © 2024 Medical Microinstruments, Inc. All Rights Reserved.